Request for Covid-19 Impact Assessment of this Report
The United States Gemigliptin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gemigliptin market, reaching US$ million by the year 2028. As for the Europe Gemigliptin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gemigliptin players cover Sanofi, LG Chem, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gemigliptin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
For Type 2 Diabetes
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Clinical Use
Hospital Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
LG Chem
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gemigliptin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gemigliptin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gemigliptin by Country/Region, 2017, 2022 & 2028
2.2 Gemigliptin Segment by Type
2.2.1 For Type 2 Diabetes
2.2.2 Others
2.3 Gemigliptin Sales by Type
2.3.1 Global Gemigliptin Sales Market Share by Type (2017-2022)
2.3.2 Global Gemigliptin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gemigliptin Sale Price by Type (2017-2022)
2.4 Gemigliptin Segment by Application
2.4.1 Clinical Use
2.4.2 Hospital Use
2.5 Gemigliptin Sales by Application
2.5.1 Global Gemigliptin Sale Market Share by Application (2017-2022)
2.5.2 Global Gemigliptin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gemigliptin Sale Price by Application (2017-2022)
3 Global Gemigliptin by Company
3.1 Global Gemigliptin Breakdown Data by Company
3.1.1 Global Gemigliptin Annual Sales by Company (2020-2022)
3.1.2 Global Gemigliptin Sales Market Share by Company (2020-2022)
3.2 Global Gemigliptin Annual Revenue by Company (2020-2022)
3.2.1 Global Gemigliptin Revenue by Company (2020-2022)
3.2.2 Global Gemigliptin Revenue Market Share by Company (2020-2022)
3.3 Global Gemigliptin Sale Price by Company
3.4 Key Manufacturers Gemigliptin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gemigliptin Product Location Distribution
3.4.2 Players Gemigliptin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gemigliptin by Geographic Region
4.1 World Historic Gemigliptin Market Size by Geographic Region (2017-2022)
4.1.1 Global Gemigliptin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gemigliptin Annual Revenue by Geographic Region
4.2 World Historic Gemigliptin Market Size by Country/Region (2017-2022)
4.2.1 Global Gemigliptin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gemigliptin Annual Revenue by Country/Region
4.3 Americas Gemigliptin Sales Growth
4.4 APAC Gemigliptin Sales Growth
4.5 Europe Gemigliptin Sales Growth
4.6 Middle East & Africa Gemigliptin Sales Growth
5 Americas
5.1 Americas Gemigliptin Sales by Country
5.1.1 Americas Gemigliptin Sales by Country (2017-2022)
5.1.2 Americas Gemigliptin Revenue by Country (2017-2022)
5.2 Americas Gemigliptin Sales by Type
5.3 Americas Gemigliptin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gemigliptin Sales by Region
6.1.1 APAC Gemigliptin Sales by Region (2017-2022)
6.1.2 APAC Gemigliptin Revenue by Region (2017-2022)
6.2 APAC Gemigliptin Sales by Type
6.3 APAC Gemigliptin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gemigliptin by Country
7.1.1 Europe Gemigliptin Sales by Country (2017-2022)
7.1.2 Europe Gemigliptin Revenue by Country (2017-2022)
7.2 Europe Gemigliptin Sales by Type
7.3 Europe Gemigliptin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gemigliptin by Country
8.1.1 Middle East & Africa Gemigliptin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gemigliptin Revenue by Country (2017-2022)
8.2 Middle East & Africa Gemigliptin Sales by Type
8.3 Middle East & Africa Gemigliptin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gemigliptin
10.3 Manufacturing Process Analysis of Gemigliptin
10.4 Industry Chain Structure of Gemigliptin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gemigliptin Distributors
11.3 Gemigliptin Customer
12 World Forecast Review for Gemigliptin by Geographic Region
12.1 Global Gemigliptin Market Size Forecast by Region
12.1.1 Global Gemigliptin Forecast by Region (2023-2028)
12.1.2 Global Gemigliptin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gemigliptin Forecast by Type
12.7 Global Gemigliptin Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Gemigliptin Product Offered
13.1.3 Sanofi Gemigliptin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
14 Research Findings and Conclusion
Table 1. Gemigliptin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gemigliptin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of For Type 2 Diabetes
Table 4. Major Players of Others
Table 5. Global Gemigliptin Sales by Type (2017-2022) & (K Units)
Table 6. Global Gemigliptin Sales Market Share by Type (2017-2022)
Table 7. Global Gemigliptin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Gemigliptin Revenue Market Share by Type (2017-2022)
Table 9. Global Gemigliptin Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Gemigliptin Sales by Application (2017-2022) & (K Units)
Table 11. Global Gemigliptin Sales Market Share by Application (2017-2022)
Table 12. Global Gemigliptin Revenue by Application (2017-2022)
Table 13. Global Gemigliptin Revenue Market Share by Application (2017-2022)
Table 14. Global Gemigliptin Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Gemigliptin Sales by Company (2020-2022) & (K Units)
Table 16. Global Gemigliptin Sales Market Share by Company (2020-2022)
Table 17. Global Gemigliptin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Gemigliptin Revenue Market Share by Company (2020-2022)
Table 19. Global Gemigliptin Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Gemigliptin Producing Area Distribution and Sales Area
Table 21. Players Gemigliptin Products Offered
Table 22. Gemigliptin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gemigliptin Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Gemigliptin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Gemigliptin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Gemigliptin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Gemigliptin Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Gemigliptin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Gemigliptin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Gemigliptin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Gemigliptin Sales by Country (2017-2022) & (K Units)
Table 34. Americas Gemigliptin Sales Market Share by Country (2017-2022)
Table 35. Americas Gemigliptin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Gemigliptin Revenue Market Share by Country (2017-2022)
Table 37. Americas Gemigliptin Sales by Type (2017-2022) & (K Units)
Table 38. Americas Gemigliptin Sales Market Share by Type (2017-2022)
Table 39. Americas Gemigliptin Sales by Application (2017-2022) & (K Units)
Table 40. Americas Gemigliptin Sales Market Share by Application (2017-2022)
Table 41. APAC Gemigliptin Sales by Region (2017-2022) & (K Units)
Table 42. APAC Gemigliptin Sales Market Share by Region (2017-2022)
Table 43. APAC Gemigliptin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Gemigliptin Revenue Market Share by Region (2017-2022)
Table 45. APAC Gemigliptin Sales by Type (2017-2022) & (K Units)
Table 46. APAC Gemigliptin Sales Market Share by Type (2017-2022)
Table 47. APAC Gemigliptin Sales by Application (2017-2022) & (K Units)
Table 48. APAC Gemigliptin Sales Market Share by Application (2017-2022)
Table 49. Europe Gemigliptin Sales by Country (2017-2022) & (K Units)
Table 50. Europe Gemigliptin Sales Market Share by Country (2017-2022)
Table 51. Europe Gemigliptin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Gemigliptin Revenue Market Share by Country (2017-2022)
Table 53. Europe Gemigliptin Sales by Type (2017-2022) & (K Units)
Table 54. Europe Gemigliptin Sales Market Share by Type (2017-2022)
Table 55. Europe Gemigliptin Sales by Application (2017-2022) & (K Units)
Table 56. Europe Gemigliptin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Gemigliptin Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Gemigliptin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Gemigliptin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Gemigliptin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Gemigliptin Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Gemigliptin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Gemigliptin Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Gemigliptin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Gemigliptin
Table 66. Key Market Challenges & Risks of Gemigliptin
Table 67. Key Industry Trends of Gemigliptin
Table 68. Gemigliptin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Gemigliptin Distributors List
Table 71. Gemigliptin Customer List
Table 72. Global Gemigliptin Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Gemigliptin Sales Market Forecast by Region
Table 74. Global Gemigliptin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Gemigliptin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Gemigliptin Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Gemigliptin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Gemigliptin Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Gemigliptin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Gemigliptin Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Gemigliptin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Gemigliptin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Gemigliptin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Gemigliptin Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Gemigliptin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Gemigliptin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Gemigliptin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Gemigliptin Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Gemigliptin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Gemigliptin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Gemigliptin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Sanofi Basic Information, Gemigliptin Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Gemigliptin Product Offered
Table 94. Sanofi Gemigliptin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 97. LG Chem Basic Information, Gemigliptin Manufacturing Base, Sales Area and Its Competitors
Table 98. LG Chem Gemigliptin Product Offered
Table 99. LG Chem Gemigliptin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. LG Chem Main Business
Table 101. LG Chem Latest Developments
List of Figures
Figure 1. Picture of Gemigliptin
Figure 2. Gemigliptin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gemigliptin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Gemigliptin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gemigliptin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of For Type 2 Diabetes
Figure 10. Product Picture of Others
Figure 11. Global Gemigliptin Sales Market Share by Type in 2021
Figure 12. Global Gemigliptin Revenue Market Share by Type (2017-2022)
Figure 13. Gemigliptin Consumed in Clinical Use
Figure 14. Global Gemigliptin Market: Clinical Use (2017-2022) & (K Units)
Figure 15. Gemigliptin Consumed in Hospital Use
Figure 16. Global Gemigliptin Market: Hospital Use (2017-2022) & (K Units)
Figure 17. Global Gemigliptin Sales Market Share by Application (2017-2022)
Figure 18. Global Gemigliptin Revenue Market Share by Application in 2021
Figure 19. Gemigliptin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Gemigliptin Revenue Market Share by Company in 2021
Figure 21. Global Gemigliptin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Gemigliptin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Gemigliptin Sales Market Share by Region (2017-2022)
Figure 24. Global Gemigliptin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Gemigliptin Sales 2017-2022 (K Units)
Figure 26. Americas Gemigliptin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Gemigliptin Sales 2017-2022 (K Units)
Figure 28. APAC Gemigliptin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Gemigliptin Sales 2017-2022 (K Units)
Figure 30. Europe Gemigliptin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Gemigliptin Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Gemigliptin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Gemigliptin Sales Market Share by Country in 2021
Figure 34. Americas Gemigliptin Revenue Market Share by Country in 2021
Figure 35. United States Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Gemigliptin Sales Market Share by Region in 2021
Figure 40. APAC Gemigliptin Revenue Market Share by Regions in 2021
Figure 41. China Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Gemigliptin Sales Market Share by Country in 2021
Figure 48. Europe Gemigliptin Revenue Market Share by Country in 2021
Figure 49. Germany Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Gemigliptin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Gemigliptin Revenue Market Share by Country in 2021
Figure 56. Egypt Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Gemigliptin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Gemigliptin in 2021
Figure 62. Manufacturing Process Analysis of Gemigliptin
Figure 63. Industry Chain Structure of Gemigliptin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...